Cited by 102Regulation of Appetite and ObesityDiabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

The Metabolic Syndrome Is Associated with Reduced Central Serotonergic Responsivity in Healthy Community Volunteers

Muldoon, Matthew F., Mackey, Rachel H., Korytkowski, Mary T., Flory, Janine D., Pollock, Bruce G., Manuck, Stephen B.·2006·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2005-1654

Open this paper in CoChat — free account

Abstract

CONTEXT: The pathobiology of the metabolic syndrome remains unclear. The central nervous system is likely to be involved via regulation of eating, physical activity, blood pressure, and metabolism. OBJECTIVE: The objective of this study was to test the hypothesis that low central serotonergic activity is associated with the metabolic syndrome. DESIGN, SETTING, PARTICIPANTS: This was a cross-sectional study of 345 healthy community volunteers, aged 30-55 yr, not taking medications for hypertension, lipid disorders, or diabetes. OUTCOME MEASURES: Central serotonergic responsivity was assessed with the iv citalopram challenge test. The serum prolactin area under the curve (AUC) over 150 min was calculated, and all analyses were adjusted for age, sex, plasma citalopram concentration, and baseline prolactin. The metabolic syndrome was defined according to the National Cholesterol Education Program (NCEP) and International Diabetes Federation (IDF) criteria. Insulin resistance was estimated by homeostasis model assessment. RESULTS: Compared with other individuals, persons meeting either NCEP or IDF criteria for the metabolic syndrome had lower mean prolactin responses (P < 0.05 for both). Using logistic regression, a decrease in prolactin AUC of 1 sd (-13.6 ng/ml.h) more than doubled the odds of having the metabolic syndrome (NCEP criteria: odds ratio, 2.38; 95% confidence interval, 1.14-4.97; P = 0.02; IDF criteria: odds ratio, 2.80; 95% confidence interval, 1.48-5.30; P = 0.002). Finally, the prolactin AUC was negatively associated with insulin resistance (beta = -0.03, P = 0.02). CONCLUSIONS: Corroborating previous evidence, the metabolic syndrome was associated with diminished brain serotonergic activity as reflected in a comparative blunting of the prolactin response to a selective serotonergic challenge. This association may have implications for the etiology, prevention, and treatment of the metabolic syndrome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1210/jc.2005-1654

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Glucose Metabolism in Patients With Schizophrenia Treated With Atypical Antipsychotic Agents
Henderson, D. C., Cagliero, E., Copeland, P. M., Borba, C. P. C., Evins, A. E., Hayden, D. L., Weber, M., Anderson, E. J., Allison, D. B., Daley, T. B., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.19 · Cited by 320
Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5‐hydroxytryptaminergic neurones. Studies with fenfluramine.
Quattrone, A., Tedeschi, G., Aguglia, U., Scopacasa, F., Renzo, G. F. D., & Annunziato, L. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02202.x · Cited by 165
Neuroendocrine probes of serotonergic function: A critical review
Yatham, L. N., & Steiner, M. S. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90696-z · Cited by 164
Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy.
Goodnick, P. J. (2001) · Annals of Clinical Psychiatry · doi:10.1023/a:1009012815127 · Cited by 146
Hypothesis: Shifting the Equilibrium From Activity to Food Leads to Autonomic Unbalance and the Metabolic Syndrome
Kreier, F., Yılmaz, A., Kalsbeek, A., Romijn, J. A., Sauerwein, H. P., Fliers, E., & Buijs, R. M. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2652 · Cited by 129
Use of Antidepressants in Treatment of Comorbid Diabetes Mellitus and Depression as Well as in Diabetic Neuropathy
Goodnick, P. J. (2001) · Annals of Clinical Psychiatry · doi:10.3109/10401230109147127 · Cited by 124
Low Central Nervous System Serotonergic Responsivity Is Associated with the Metabolic Syndrome and Physical Inactivity
Muldoon, M. F., Mackey, R. H., Williams, K. V., Korytkowski, M. T., Flory, J. D., & Manuck, S. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031295 · Cited by 123

Show all 19 references

Research works printed but not linked: 1

Sanders-Bush, 2001, 5-Hydroxytryptamine (serotonin) receptor agonists and antagonists, In: Hardman JG, Limbird LE, eds. Goodman, Gilman’s the pharmacological basis of therapeutics. New York: McGraw-Hill;, 269

Sorted by citations

Self-reported sleep quality is associated with the metabolic syndrome
Jennings, J. R., Muldoon, M. F., Hall, M., Buysse, D. J., & Manuck, S. B. (2007) · Sleep · doi:10.1093/sleep/30.2.219 · Cited by 344
Depressive Symptoms and Stressful Life Events Predict Metabolic Syndrome Among Middle-Aged Women
Räikkönen, K., Matthews, K. A., & Kuller, L. H. (2007) · Diabetes Care · doi:10.2337/dc06-1857 · Cited by 279
Endocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221
Are psychological characteristics related to risk of the metabolic syndrome? A review of the literature
Goldbacher, E. M., & Matthews, K. A. (2007) · Annals of Behavioral Medicine · doi:10.1007/bf02874549 · Cited by 196
The hormonal control of ejaculation
Corona, G., Jannini, E. A., Vignozzi, L., Rastrelli, G., & Maggi, M. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.147 · Cited by 189
Hypoprolactinemia: A New Clinical Syndrome in Patients with Sexual Dysfunction
Corona, G., Mannucci, E., Jannini, E. A., Lotti, F., Ricca, V., Monami, M., Boddi, V., Bandini, E., Balercia, G., Forti, G., et al. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01206.x · Cited by 175
Lifetime History of Major Depression Predicts the Development of the Metabolic Syndrome in Middle-Aged Women
Goldbacher, E. M., Bromberger, J. T., & Matthews, K. A. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318197a4d5 · Cited by 166
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome
Vignozzi, L., Gacci, M., & Maggi, M. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2015.301 · Cited by 165
Premature and delayed ejaculation: two ends of a single continuum influenced by hormonal milieu
Corona, G., Jannini, E. A., Lotti, F., Boddi, V., Vita, G. D., Forti, G., Lenzi, A., Mannucci, E., & Maggi, M. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01059.x · Cited by 161
Hormonal Causes of Male Sexual Dysfunctions and Their Management (Hyperprolactinemia, Thyroid Disorders, GH Disorders, and DHEA)
Maggi, M., Buvat, J., Corona, G., Guay, A. T., & Torres, L. O. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02735.x · Cited by 155
Management of antipsychotic-related weight gain
Maayan, L. A., & Correll, C. U. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.85 · Cited by 132
Obesity – A neuropsychological disease? Systematic review and neuropsychological model
Jauch‐Chara, K., & Oltmanns, K. M. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.12.001 · Cited by 136
Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome
Corona, G., Forti, G., & Maggi, M. (2008) · The Aging Male · doi:10.1080/13685530802468497 · Cited by 107
Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes?
Balbach, L., Wallaschofski, H., Völzke, H., Nauck, M. A., Dörr, M., & Haring, R. (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-12 · Cited by 105
Association between suicidal behaviour and impaired glucose metabolism in depressive disorders
Koponen, H., Kautiainen, H., Leppänen, E., Mäntyselkä, P. T., & Vanhala, M. J. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0567-x · Cited by 103
METABOLIC SYNDROME IN THE ELDERLY: AN OVERVIEW OF THE EVIDENCE
Denys, K., Cankurtaran, M., Janssens, W. H., & Petrovic, M. (2009) · Acta Clinica Belgica · doi:10.1179/acb.2009.006 · Cited by 108
No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study
Hildrum, B., Mykletun, A., Midthjell, K., Ismail, K., & Dahl, A. A. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01315.x · Cited by 101
The Effect of Statin Therapy on Testosterone Levels in Subjects Consulting for Erectile Dysfunction
Corona, G., Boddi, V., Balercia, G., Rastrelli, G., Vita, G. D., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01698.x · Cited by 99
Low Prolactin Is Associated with Sexual Dysfunction and Psychological or Metabolic Disturbances in Middle-Aged and Elderly Men: The European Male Aging Study (EMAS)
Corona, G., Wu, F. C. W., Rastrelli, G., Lee, D. M., Forti, G., O'Connor, D. B., O’Neill, T. W., Pendleton, N., Bártfai, G., Boonen, S., et al. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12327 · Cited by 90
Stroke‐Independent Association Between Metabolic Syndrome and Functional Dependence, Depression, and Low Quality of Life in Elderly Community‐Dwelling Brazilian People
Roriz‐Cruz, M., Rosset, I., Wada, T., Sakagami, T., Ishine, M., Filho, J. D. S. R., Cruz, T. R. S., Rodrigues, R. A. P., Resmini, I., Sudoh, S., et al. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01068.x · Cited by 89
Neurobiological Functioning and the Personality-Trait Hierarchy: Central Serotonergic Responsivity and the Stability Metatrait
Wright, A. G. C., Creswell, K. G., Flory, J. D., Muldoon, M. F., & Manuck, S. B. (2019) · Psychological Science · doi:10.1177/0956797619864530 · Cited by 89
Preclinical Atherosclerosis Covaries with Individual Differences in Reactivity and Functional Connectivity of the Amygdala
Gianaros, P. J., Hariri, A. R., Sheu, L. K., Muldoon, M. F., Sutton-Tyrrell, K., & Manuck, S. B. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.007 · Cited by 89
The role of prolactin in andrology: what is new?
Rastrelli, G., Corona, G., & Maggi, M. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9322-3 · Cited by 87
Anger and the Heart: Perspectives on Cardiac Risk, Mechanisms and Interventions
Suls, J. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.03.002 · Cited by 93
Erectile dysfunction and cardiovascular risk: a review of current findings
Corona, G., Rastrelli, G., Isidori, A. M., Pivonello, R., Bettocchi, C., Reisman, Y., Sforza, A., & Maggi, M. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1745632 · Cited by 80
The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes
Derkach, K. V., Бондарева, В. М., Chistyakova, O. V., Berstein, L. M., & Shpakov, A. O. (2015) · International Journal of Endocrinology · doi:10.1155/2015/245459 · Cited by 72
Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol
KRAKOWSKI, M. I., Czobor, P., & Citrome, L. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.02.006 · Cited by 74
The Association Between Prolactin and Metabolic Parameters in PCOS Women: A Retrospective Analysis
Yang, H., Di, J., Pan, J., Yu, R., Teng, Y., Cai, Z., & Deng, X. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00263 · Cited by 73
Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis
Mak, K. K., Kong, W. Y., Mak, A., Sharma, V. K., & Ho, R. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303791 · Cited by 74
Hostility and Health
Barefoot, J. C., & Williams, R. B. (2010) · Springer eBooks · doi:10.1007/978-0-387-09488-5_13 · Cited by 56
Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction
Corona, G., Rastrelli, G., Boddi, V., Monami, M., Melani, C., Balzi, D., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01076.x · Cited by 56
The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes
Iordanidou, M., Tavridou, A., Petridis, I., Arvanitidis, K. I., Christakidis, D., Vargemezis, V. A., & Manolopoulos, V. G. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.10.022 · Cited by 54
Serotonin Receptor 2A ( HTR2A ) Gene Polymorphisms Are Associated with Blood Pressure, Central Adiposity, and the Metabolic Syndrome
Halder, I., Muldoon, M. F., Ferrell, R. E., & Manuck, S. B. (2007) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2007.0008 · Cited by 52
A Dietary Fat Excess Alters Metabolic and Neuroendocrine Responses Before the Onset of Metabolic Diseases
Banas, S. M., Rouch, C., Kassis, N., Markaki, E. M., & Gerozissis, K. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-008-9307-9 · Cited by 48
Citalopram intervention for hostility: Results of a randomized clinical trial.
Kamarck, T. W., Haskett, R. F., Muldoon, M. F., Flory, J. D., Anderson, B. J., Bies, R. R., Pollock, B. G., & Manuck, S. B. (2009) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0014394 · Cited by 48
Lower Central Serotonergic Responsivity Is Associated With Preclinical Carotid Artery Atherosclerosis
Muldoon, M. F., Mackey, R. H., Sutton‐Tyrrell, K., Flory, J. D., Pollock, B. G., & Manuck, S. B. (2007) · Stroke · doi:10.1161/strokeaha.106.477638 · Cited by 43
Association between depression and metabolic syndrome in korean women: Results from the korean national health and nutrition examination survey (2007–2013)
Park, S. J., Roh, S., Hwang, J., Kim, H. A., Kim, S., Lee, T. K., Kang, S. H., Ha, Y., Jang, J., & Park, S. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.022 · Cited by 41
Hostility, anger, and cardiovascular mortality among blacks and whites
Assari, S. (2016) · Research in Cardiovascular Medicine · doi:10.5812/cardiovascmed.34029 · Cited by 39
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression
Kloiber, S. M., Kohli, M. A., Brueckl, T., Ripke, S., Ising, M., Uhr, M., Menke, A., Unschuld, P. G., Horstmann, S., Salyakina, D., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.142 · Cited by 37
Depression is associated with the metabolic syndrome among patients with type 1 diabetes
Ahola, A. J., Thorn, L. M., Saraheimo, M., Forsblom, C. M., Groop, P., & on behalf of the Finndiane Study Group (2010) · Annals of Medicine · doi:10.3109/07853890.2010.503660 · Cited by 37
Type 2 Diabetes--An Introduction to the Development and Use of Animal Models
Kaplan, J. R., & Wagner, J. D. (2006) · ILAR Journal · doi:10.1093/ilar.47.3.181 · Cited by 36
A Polymorphism in the Serotonin Transporter Gene Moderates Cardiovascular Reactivity to Psychosocial Stress
Way, B. M., & Taylor, S. E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31821195ed · Cited by 35
Association study of serotonergic gene variants with antipsychotic-induced adverse reactions
Al-Janabi, I. I., Arranz, M. J., Blakemore, A. I. F., Sáiz, P. A., Susce, M. T., Glaser, P. E. A., Clark, D. L., & de León, J. (2009) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3283328dcd · Cited by 33
The lack of association between components of metabolic syndrome and treatment resistance in depression
Šagud, M., Mihaljević-Peleš, A., Uzun, S., Ćusa, B. V., Kozumplik, O., Mikulić, S. K., Mustapić, M., Barišić, I., Mück‐Šeler, D., & Pivac, N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3085-x · Cited by 34
Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinations
Zelber‐Sagi, S., Toker, S., Armon, G., Melamed, S., Berliner, S. A., Shapira, I., Halpern, Z., Santo, E., & Shibolet, O. (2013) · Psychological Medicine · doi:10.1017/s0033291713000500 · Cited by 31
Association of metabolic syndrome with reduced central serotonergic activity
Herrera, R., Hernández‐Rodríguez, J., Serrano, J. M. M., de Oca, A. B.-M., & Manjarrez‐Gutiérrez, G. (2010) · Metabolic Brain Disease · doi:10.1007/s11011-010-9229-3 · Cited by 29
High sucrose consumption induces memory impairment in rats associated with electrophysiological modifications but not with metabolic changes in the hippocampus
Lemos, C., Rial, D., Gonçalves, F. Q., Pires, J., Silva, H. B. L., MATHEUS, F. C., Silva, A. C., Marques, J. M., Rodrigues, R. J., Jarak, I., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.018 · Cited by 32
Food insecurity is an important risk factor for type 2 diabetes: a case-control study of new referrals to the University clinics, Shiraz, Southern Iran
Najibi, N., Firoozi, R., Shahrezaee, S., Eshraghian, M., Daneshi‐Maskooni, M., & Motlagh, A. D. (2019) · BMC Public Health · doi:10.1186/s12889-019-7236-9 · Cited by 28
Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building
Sherer, E. A., Sale, M. E., Pollock, B. G., Belani, C. P., Egorin, M. J., Ivy, P. S., Lieberman, J. A., Manuck, S. B., Marder, S. R., Muldoon, M. F., et al. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9258-0 · Cited by 29
Metabolic and reproductive consequences of the serotonin transporter promoter polymorphism (5-HTTLPR) in adult female rhesus monkeys (Macaca mulatta)
Hoffman, J. B., Kaplan, J. R., Kinkead, B. L., Berga, S. L., & Wilson, M. E. (2007) · Endocrine · doi:10.1007/s12020-007-0017-8 · Cited by 27
Immune cells and metabolic dysfunction
Eheim, A. L., Medříková, D., & Herzig, S. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0403-7 · Cited by 27
Increased inflammation and lower platelet 5-HT in depression with metabolic syndrome
Silić, A., Karlović, D., & Serretti, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.019 · Cited by 24
Association between triglyceride glucose index and suicide attempts in patients with first-episode drug-naïve major depressive disorder
Liu, J., Zhu, X., Liu, Y., Jia, F., Yuan, H., Wang, Q., Zhang, X., Li, Z., Du, X., & Zhang, X. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1231524 · Cited by 25
Association between symptoms of depression, diabetes complications and vascular risk factors in four European cohorts of individuals with type 1 diabetes – InterDiane Consortium
Ahola, A. J., Radzevičienė, L., Zaharenko, L., Bulum, T., Skrebinska, S., Prakapienė, E., Blaslov, K., Roso, V., Rovīte, V., Pīrāgs, V., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108495 · Cited by 24
Association of metabolic syndrome and its components with suicidal ideation and depression in adults: A nationally representative sample of the Korean population
Ko, J.-K., Han, K., Shin, C., Lee, S., Han, C., Kim, Y., Yoon, H.-K., & Ko, Y. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.049 · Cited by 26
Sex- and age-specific associations between major depressive disorder and metabolic syndrome in two general population samples in Germany
Block, A., Schipf, S., der Auwera, S. V., Hannemann, A., Nauck, M. A., John, U., Völzke, H., Freyberger, H. J., Dörr, M., Felix, S. B., et al. (2016) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2016.1191535 · Cited by 26
An investigation of the association between the level of prolactin in serum and type II diabetes
Manshaei, N., Shakibaei, F., Fazilati, M., Salavati, H., Negahdary, M., & Palizban, A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.07.007 · Cited by 21
Metabolic and Cardiovascular Outcomes of Fatherhood: Results from a Cohort of Study in Subjects with Sexual Dysfunction
Fisher, A. D., Rastrelli, G., Bandini, E., Corona, G., Balzi, D., Melani, C., Monami, M., Matta, V., Mannucci, E., & Maggi, M. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02865.x · Cited by 20
Increased Prolactin is an Adaptive Response to Protect Against Metabolic Disorders in Obesity
Liu, J., Wang, Q., Zhang, L., Fu, J., An, Y., Meng, H., & Wang, G. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.01.002 · Cited by 19
Dietary Tryptophan and the Risk of Metabolic Syndrome: Total Effect and Mediation Effect of Sleep Duration
Wang, W., Liu, L., Tian, Z., Han, T., Sun, C., & Li, Y. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s337171 · Cited by 19
Basal ganglia morphology links the metabolic syndrome and depressive symptoms
Onyewuenyi, I. C., Muldoon, M. F., Christie, I. C., Erickson, K. I., & Gianaros, P. J. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.09.014 · Cited by 18
Diabetes and Obesity Research using Nonhuman Primates
Wagner, J. D., Cann, J. A., Zhang, L., & Harwood, H. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381366-4.00014-6 · Cited by 17
National Cholesterol Educational Program and International Diabetes Federation diagnostic criteria for metabolic syndrome in an Italian cohort: Results from the FIBAR Study
Mannucci, E., Monami, M., Bardini, G., Ognibene, A., & Rotella, C. M. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03349239 · Cited by 16
A study of central serotoninergic activity in healthy subjects and patients with Type 2 diabetes treated by traditional one-to-one care or Group Care
Trento, M., Kucich, C., Tibaldi, P., Gennari, S. M., Tedesco, S., Balbo, M. L., Arvat, E., Cavallo, F., Ghigo, E., & Porta, M. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346660 · Cited by 15
Citalopram improves metabolic risk factors among high hostile adults: Results of a placebo-controlled intervention
Kamarck, T. W., Muldoon, M. F., Manuck, S. B., Haskett, R. F., Cheong, J., Flory, J. D., & Vella, E. J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.01.005 · Cited by 14
How Metabolic State May Regulate Fear: Presence of Metabolic Receptors in the Fear Circuitry
Koorneef, L., Bogaards, M., Reinders, M., Meijer, O., & Mahfouz, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00594 · Cited by 15
The Physiology of Aggression
Watve, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4409-1_7 · Cited by 13
Non-alcoholic Fatty Liver Disease and Depression: Evidence for Genotype × Environment Interaction in Mexican Americans
Manusov, E. G., Diego, V. P., Sheikh, K., Laston, S., Blangero, J., & Williams‐Blangero, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.936052 · Cited by 11
Depressive symptoms and 5-year incident metabolic syndrome among older adults
Wu, Q., Hua, Y.-Y., Ma, Q., Xu, Y., Chen, X., & Pan, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-94503-y · Cited by 11
The hormonal regulation of men’s sexual desire, arousal, and penile erection: recommendations from the fifth international consultation on sexual medicine (ICSM 2024)
Rastrelli, G., Antonio, L., Carrier, S., Isidori, A. M., & Maggi, M. (2025) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeaf025 · Cited by 9
Associations between Central Nervous System Serotonin, Fasting Glucose, and Hostility in African American Females
Boyle, S. H., Georgiades, A., Brummett, B. H., Barefoot, J. C., Siegler, I. C., Matson, W. R., Kuhn, C. M., Grichnik, K. P., Stafford‐Smith, M., Williams, R. B., et al. (2014) · Annals of Behavioral Medicine · doi:10.1007/s12160-014-9626-7 · Cited by 9
High-fat simple carbohydrate (HFSC) diet impairs hypothalamic and corpus striatal serotonergic metabolic pathway in metabolic syndrome (MetS) induced C57BL/6J mice
D’Souza, S., & Abraham, A. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1354511 · Cited by 8
Self-rated health may be a predictor for metabolic syndrome and high hs-CRP prevalences in healthy adults in South Korea: Based on the 2015 Korea National Health and Nutrition Examination Survey
Kim, M. J., & Kim, I. W. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.03.003 · Cited by 7
Evaluating associations between metabolic health, obesity and depressive symptoms: a prospective analysis of data from the English Longitudinal Study of Ageing (ELSA) with a 2‑year follow‑up
Slater, N., Rowley, C. E., Venables, R. H., White, S. J., & Frisher, M. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-025394 · Cited by 7
Serotonin Level and Lipid Metabolism Indices in Patients with Irritable Bowel Syndrome with Constipation Against the Background of Various Degrees of Obesity
Mishchuk, V. G., & GRYGORUK, G. V. (2018) · Galician Medical Journal · doi:10.21802/gmj.2018.2.1 · Cited by 6
Correlation between brain neurotransmitters and insulin sensitivity:Neuro-preservative role of resveratrol against high fat, highfructose-induced insulin resistance
Ahmed, R. F., Awdan, S. A. E., Jaleel, G. A. A., Saleh, D. O., & Ahmed-Farid, O. A.-H. (2020) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2020.102005 · Cited by 6
Infusion of a Lipid Emulsion in Healthy Men Decreases the Serotonergic Response
Sondermeijer, B. M., Twennaar, C. F. K., Kastelein, J. J. P., Franssen, E. J. F., Hutten, B. A., Dallinga‐Thie, G. M., Stroes, E. S. G., Fliers, E., Twickler, M., & Serlie, M. J. M. (2012) · Neuroendocrinology · doi:10.1159/000333038 · Cited by 5
Acquired hypoprolactinemia in men, possible phenotype
Corona, G., Rastrelli, G., Sparano, C., Vignozzi, L., & Maggi, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09895-9 · Cited by 4
Variety of Serotonin Levels in Pediatric Gastrointestinal Disorders
Matiș, L., Daina, L., Mariș, L., Ghitea, T. C., Trifan, D. F., Moga, I., & Fodor, R. (2023) · Diagnostics · doi:10.3390/diagnostics13243675 · Cited by 4
Socioeconomic status moderates associations between CNS serotonin and expression of β2-integrins CD11b and CD11c
Brummett, B. H., Boyle, S. H., Kuhn, C. M., Siegler, I. C., & Williams, R. B. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.09.004 · Cited by 4
Metabolic syndrome & psychiatric disorders.
Sm, S., & Mattoo, S. (2008) · PubMed · Cited by 4
The personality meta‐trait of stability and carotid artery atherosclerosis
Ringwald, W. R., Kaurin, A., DuPont, C. M., Gianaros, P. J., Marsland, A. L., Muldoon, M. F., Wright, A. G. C., & Manuck, S. B. (2022) · Journal of Personality · doi:10.1111/jopy.12716 · Cited by 3
Cardiovascular Disease Burden in Persons with Mental Illness: Comparison between a U.S. Psychiatry Outpatient Sample and a U.S. General Population Sample
Dhingra, R., He, F., Saunders, E. F. H., Waschbusch, D. A., Pearl, A. M., Bixler, E. O., Greaney, J. L., Swigart, A. R., Al‐Shaar, L., Chinchilli, V. M., et al. (2024) · Mental Illness · doi:10.1155/2024/1689172 · Cited by 4
Endocrine Control of Ejaculation
Corona, G., Rastrelli, G., Vignozzi, L., & Maggi, M. (2012) · Springer eBooks · doi:10.1007/978-88-470-2646-9_12 · Cited by 3
Fluoxetine and metformin combined treatment decreases insulin resistance in patients with metabolic syndrome
Manjarrez‐Gutiérrez, G., Herrera, R., Lara-Pérez, G., Serrano-Hernández, Y., Mondragón-Herrera, J. A., & Hernández‐Rodríguez, J. (2020) · Trends in Diabetes and Metabolism · doi:10.15761/tdm.1000117 · Cited by 2
7. Serotonergic and Parasympathetic Disorders
Hellhammer, D. H., & Klingmann, P. O. (2008) · KARGER eBooks · doi:10.1159/000119049 · Cited by 2
Poststroke depression and 5-HTTLPR
Queirazza, F., & Cavanagh, J. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304149 · Cited by 2
Is prolactin involved in the evolution of atherothrombotic disease?
Reuwer, A. Q., Hoekstra, M., Touraine, P. A., Twickler, T. B., & Goffin, V. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.23 · Cited by 2
Baseline Lipid Levels and Acute Treatment Response to Paroxetine and Tianeptine in Depressed Women
Mück‐Šeler, D., Šagud, M., Mihaljevi-Peles, A., Jakovljevi, M., & Pivac, N. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318218f45f · Cited by 2
Underlying biological substrates associated with cognitive dysfunction in major depressive disorder
(2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139860567.012 · Cited by 2
Centro de Ciências da Saúde
Autores, V. (2019) · Revista Guará · doi:10.30712/guara.v6i9.23306 · Cited by 2
Peripheral and central serotonin in the regulation of glucose metabolism
Serlie, M. J. M. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00045-1 · Cited by 2
Psychiatric Illness, Psychotropic Medication, and Childhood Obesity
Maayan, L. A., & Citrome, L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374995-6.10025-8 · Cited by 2
Psychological determinants and self care in patients with type 1 diabetes
Ahola, A. J. (2012) · Työväentutkimus Vuosikirja · Cited by 2
Hostility and Health
Barefoot, J. C., & Williams, R. B. (2022) · Springer eBooks · doi:10.1007/978-0-387-85960-6_20 · Cited by 2
Metabolic and Behavioral Effects of Serotonergic Antidepressants in Rats Exposed to Swim Endurance Stress
Gitay, M. N., & Bano, S. (2013) · Journal of Basic & Applied Sciences · doi:10.6000/1927-5129.2013.09.35 · Cited by 1
Exploring the neurobiological markers of suicidal behaviors in pediatric population: a narrative review
Salehi, M., Saeidi, M., Amanat, M., Barias, T., Anyeji, U., Alzein, O., & Gunturu, S. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1738009
“Reduced serotonin availability has been linked to increased appetite and weight gain, central adiposity, impaired glucose tolerance, and insulin resistance, alongside depressed mood (88).”
Fibromialgia e síndrome metabólica: alterações neuroendócrinas em comum
Gagliardi, A., Alambert, P. A., dos Santos, L. R., Hime, R. C., Filho, E. R. A., Póvoa, F. F., & Contenças, A. C. D. S. (2009) · Diagn. tratamento
The Metabolic Syndrome Is Associated with Reduced Central Serotonergic Responsivity in Healthy Community Volunteers
Buckley, P. F. (2008) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70886-7
Insulin resistance and implications for hippocampal volume/function and the default mode network
Kenna, H. A., Wroolie, T., Balzafiore, D. R., & Rasgon, N. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139860567.016

Authors: Muldoon, M. F., Mackey, R. H., Korytkowski, M. T., Flory, J. D., Pollock, B. G., & Manuck, S. B.
Affiliations: University of Pittsburgh (US)
Departments of Medicine and Epidemiology (R.H.M.), Pittsburgh, Pennsylvania 15260
Endocrinology (M.T.K.), Pittsburgh, Pennsylvania 15260
Icahn School of Medicine at Mount Sinai (US)
University of Toronto (CA)
Corresponding author: Muldoon, Matthew F.
ORCID: Muldoon, Matthew F.
Mackey, Rachel H.
Korytkowski, Mary T.
Flory, Janine D.
Pollock, Bruce G.
Manuck, Stephen B.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2006-02-01
Volume: 91
Issue: 2
Pages: 718-721
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2005-1654
OpenAlex: W2003538836
Cited by: 102
References: 19
Citations by year: 2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 5 · 2015: 6 · 2014: 2 · 2013: 10 · 2012: 12
FWCI: 3.52
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: University of Pittsburgh
National Institutes of Health
National Heart, Lung, and Blood Institute (P01HL040962)
National Institute of Mental Health (K24MH065416)
National Center for Research Resources (M01RR000056)
Topics: Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: metabolic syndrome, prolactin, insulin resistance, hypothalamic-pituitary regulation, healthy adults
MeSH terms: Adult, Brain, Cross-Sectional Studies, Female, Humans, Insulin Resistance, Male, Middle Aged, Prolactin, Serotonin, Citalopram, Logistic Models, Selective Serotonin Reuptake Inhibitors, Area Under Curve, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Metabolic Syndrome Is Associated with Reduced Central Serotonergic Responsivity in Healthy Community Volunteers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks